COVID-19 tracker: Pfizer targets variant-specific vaccine by fallnews2022-04-13T18:42:33+00:00April 13th, 2022|Fierce Pharma|
COVID-19 tracker: FDA grants authorization for first coronavirus breathalyzernews2022-04-13T18:42:33+00:00April 13th, 2022|Fierce Pharma|
COVID-19 tracker: Bayer faces wrongful termination lawsuit after vaccine-related dismissalnews2022-04-13T18:42:33+00:00April 13th, 2022|Fierce Pharma|
COVID-19 tracker: Poland pulls out of Pfizer vaccine contracts; J&J suspends vaccine sales forecastsnews2022-04-13T18:42:33+00:00April 13th, 2022|Fierce Pharma|
COVID-19 tracker: Arcturus moves toward pivotal booster studynews2022-04-13T18:42:33+00:00April 13th, 2022|Fierce Pharma|
COVID-19 tracker: UK study finds strong responses 84 days after booster shotnews2022-04-13T18:42:33+00:00April 13th, 2022|Fierce Pharma|
COVID-19 tracker: Novavax starts booster trial in teensnews2022-04-13T18:42:33+00:00April 13th, 2022|Fierce Pharma|
COVID-19 tracker: US government will make Pfizer’s Paxlovid available at all pharmaciesnews2022-04-13T18:42:33+00:00April 13th, 2022|Fierce Pharma|
COVID-19 tracker: Amnesty International urges investors to push for universal vaccine distributionnews2022-04-13T18:42:33+00:00April 13th, 2022|Fierce Pharma|
COVID-19 tracker: Pfizer, BioNTech seek booster nod for kids 5 to 11news2022-04-13T18:42:33+00:00April 13th, 2022|Fierce Pharma|
